ReviewSARS-CoV-2 Vaccine Development: Current Status
Abbreviations and Acronyms
Cited by (0)
Potential Competing Interests: Dr Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories and is a consultant on vaccine development for Merck & Co, Inc, Avianax LLC, Adjuvance Technologies Inc, Valneva SE, Medicago Inc, GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc, Dynavax Technologies, Genentech, Inc, Eli Lilly and Company, Janssen Global Services, LLC, Kentucky BioProcessing, Inc, and Genevant Sciences Corporation. Drs Poland, Ovsyannikova, and Kennedy hold patents related to vaccinia, influenza, and measles peptide vaccines and have received grant funding from ICW Healthcare Ventures for preclinical studies on a peptide-based COVID-19 vaccine. Dr Kennedy has received funding from Merck Research Laboratories to study waning immunity to mumps vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. Dr Crooke reports no competing interests.